This suggests that ASCC3 may participate in repairing damage to immune-positive regulatory cells associated with T cells, thereby maintaining anti-tumor immune efficacy and inhibiting tumor immune evasion (Barnett and Barnett, 1998). The gene discussed is ASCC3; the disease is neoplasm.